Table 2.
(A) The number and prevalence of BP1–BP2 deletions in non-syndromic CVM cases compared with controls in UK Biobank. (B) The number and prevalence of BP1–BP2 deletions in neuropsychiatric cases compared to controls in UK Biobank.
| BP1–BP2 del | No BP1–BP2 del | Prevalence | |
|---|---|---|---|
| A | |||
| Non-CVM controls | 1769 | 470,611 | 0.38% |
| All non-syndromic CVM samples | 18 | 2774 | 0.64% |
| B | |||
| Non-neuropsychiatric controls | 1808 | 481,522 | 0.37% |
| Neuropsychiatric cases | 24 | 3480 | 0.68% |